WordNet

immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
type genus of the family Pseudomonodaceae (同)genus Pseudomonas

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 緑膿菌感染症の疫学、微生物学、および病因 epidemiology microbiology and pathogenesis of pseudomonas aeruginosa infection
2. 造血細胞移植の候補者およびレシピエントにおける予防接種 immunizations in hematopoietic cell transplant candidates and recipients
3. 嚢胞性線維症：肺疾患に対する抗菌薬療法 cystic fibrosis antibiotic therapy for lung disease
4. 成人における気管支拡張症の治療 treatment of bronchiectasis in adults
5. 肺移植後の細菌感染症 bacterial infections following lung transplantation

Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice.

Guan Q1, Wang X, Wang X, Teng D, Mao R, Zhang Y, Wang J.
Applied microbiology and biotechnology.Appl Microbiol Biotechnol.2015 Jan 8. [Epub ahead of print]
Pathogenic Escherichia coli (E. coli) is an important infectious Gram-negative bacterium causing millions of death every year. Outer membrane protein A (OmpA) has been suggested as a potential vaccine candidate for conferring protection against bacterial infection. In this study, a universal vaccine
PMID 25567514

Protective efficacy of recombinant exotoxin A - flagellin fusion protein against Pseudomonas aeruginosa infection.

Farajnia S1, Peerayeh SN, Tanomand A, Majidi J, Goudarzi G, Naghili B, Rahbarnia L.
Canadian journal of microbiology.Can J Microbiol.2015 Jan;61(1):60-4. doi: 10.1139/cjm-2014-0501.
Pseudomonas aeruginosa is an opportunistic bacterium that causes serious nosocomial infection in immunocompromised patients. The aim of this study was to prepare a fusion protein consisting of exotoxin A (ExoA) and flagellin (Fla) from P. aeruginosa and to evaluate its potential as a vaccine candida
PMID 25496361

Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.

Farjah A1, Owlia P, Siadat SD, Mousavi SF, Ardestani MS, Mohammadpour HK.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.APMIS.2014 Dec 3. doi: 10.1111/apm.12337. [Epub ahead of print]
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious infections, is usually resistant to antimicrobial agents, and is the leading cause of morbidity and premature mortality in patients with cystic fibrosis (CF). Mucoid strains of P. aeruginosa produce a virulence factor known as a
PMID 25470757

Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia

Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice